We are live on ! Find out more
EFTRW

eFFECTOR Therapeutics, Inc. Warrant
EFTRW

Delisted

EFTRW was delisted on the 2nd of July, 2024.

Back to rankings

17 hedge funds and large institutions have $1.31M invested in eFFECTOR Therapeutics, Inc. Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 17 → 17 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

55% less capital invested

Capital invested by funds: $2.94M → $1.31M (-$1.63M)

Holders
17
Holders Change
–
Holders Change %
0%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
2
Calls
$98K
Puts
–
Net Calls
+$98K
Net Calls Change
-$386K

Top Buyers

Rank Fund Capital Flow
1
WA
Whitebox Advisors
Minnesota
+$152K
2
PA
Parallel Advisors
California
+$25.4K
3
KSCM
Kamunting Street Capital Management
Florida
+$8.48K
4
ICM
III Capital Management
Florida
+$8.08K
5
UBS Group
UBS Group
Switzerland
+$1.15K

Top Sellers

Rank Fund Capital Flow
1
AC
Aristeia Capital
Connecticut
-$59.9K
2
ICMH
Integrity Capital Management (HK)
Hong Kong
-$58K
3
CS
Credit Suisse
Switzerland
-$42K
4
CH
CVI Holdings
Delaware
-$10.3K
5
WAM
Wolverine Asset Management
Illinois
-$7.36K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Aristeia Capital
Connecticut
$634K -$59.9K -117,859 -7%
Goldman Sachs
2
Goldman Sachs
New York
$175K – – –
HCM
3
Highbridge Capital Management
New York
$140K – – –
WA
4
Whitebox Advisors
Minnesota
$128K +$152K +298,145 New
MI
5
MMCAP International
Cayman Islands
$63K – – –
PVI
6
Pura Vida Investments
New York
$35K – – –
CH
7
CVI Holdings
Delaware
$24K -$10.3K -20,186 -23%
PA
8
Parallel Advisors
California
$23K +$25.4K +50,000 +1,500%
ICM
9
III Capital Management
Florida
$16K +$8.08K +15,895 +61%
WAM
10
Wolverine Asset Management
Illinois
$14K -$7.36K -14,476 -30%
TCM
11
Tenor Capital Management
New York
$14K – – –
EPM
12
Equitec Proprietary Markets
Illinois
$13K – – –
CL
13
CSS LLC
Illinois
$12K -$5.34K -10,500 -27%
HF
14
HRT Financial
New York
$10K – – –
KSCM
15
Kamunting Street Capital Management
Florida
$6K +$8.48K +16,666 New
JG
16
Jefferies Group
New York
$4.3K – – –
UBS Group
17
UBS Group
Switzerland
$1K +$1.15K +2,254 +284%
ICMH
18
Integrity Capital Management (HK)
Hong Kong
– -$58K -66,181 Closed
CS
19
Credit Suisse
Switzerland
– -$42K -47,299 Closed

EFTRW Hedge Fund Activity: Q1 2022 in Review

17 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in eFFECTOR Therapeutics, Inc. Warrant (EFTRW) for Q1 2022, worth a combined $1.31M — down 55% from $2.94M a quarter earlier.

Fund positioning in EFTRW was balanced in Q1 2022: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 4 trimmed.

The largest buyer was Whitebox Advisors, opening a new position worth an estimated $152K. The largest seller was Aristeia Capital, cutting an estimated $59.9K.

  • 17 institutional investors held eFFECTOR Therapeutics, Inc. Warrant (EFTRW) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $1.31M of eFFECTOR Therapeutics, Inc. Warrant stock for Q1 2022, down 55% quarter-over-quarter.
  • 2 funds opened new eFFECTOR Therapeutics, Inc. Warrant positions in Q1 2022 and 2 closed out, a net change of 0 holders.
  • The largest eFFECTOR Therapeutics, Inc. Warrant buyer in Q1 2022 was Whitebox Advisors, an estimated $152K added.
  • The largest eFFECTOR Therapeutics, Inc. Warrant seller in Q1 2022 was Aristeia Capital, an estimated $59.9K sold.

Based on aggregated 13F filings for Q1 2022.